Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 29

Cited In for PubMed (Select 18554712)

1.

Toxins and virulence factors of enterotoxigenic Escherichia coli associated with strains isolated from indigenous children and international visitors to a rural community in Guatemala.

Torres OR, González W, Lemus O, Pratdesaba RA, Matute JA, Wiklund G, Sack DA, Bourgeois AL, Svennerholm AM.

Epidemiol Infect. 2015 Jun;143(8):1662-71. doi: 10.1017/S0950268814002295. Epub 2014 Sep 19.

2.

Epicutaneous Immunotherapy for Aeroallergen and Food Allergy.

Senti G, von Moos S, Kündig TM.

Curr Treat Options Allergy. 2013 Dec 17;1:68-78. eCollection 2014. Review.

3.

Immunostimulant patches containing Escherichia coli LT enhance immune responses to DNA- and recombinant protein-based Alzheimer's disease vaccines.

Davtyan H, Ghochikyan A, Hovakimyan A, Petrushina I, Yu J, Flyer D, Madsen PJ, Pedersen LO, Cribbs DH, Agadjanyan MG.

J Neuroimmunol. 2014 Mar 15;268(1-2):50-7. doi: 10.1016/j.jneuroim.2014.01.002. Epub 2014 Jan 15.

4.

Parenteral Adjuvant Effects of an Enterotoxigenic Escherichia coli Natural Heat-Labile Toxin Variant.

Braga CJ, Rodrigues JF, Medina-Armenteros Y, Farinha-Arcieri LE, Ventura AM, Boscardin SB, Sbrogio-Almeida ME, Ferreira LC.

Front Immunol. 2014 Jan 7;4:487. doi: 10.3389/fimmu.2013.00487. eCollection 2014 Jan 7.

5.

Recent advances in understanding enteric pathogenic Escherichia coli.

Croxen MA, Law RJ, Scholz R, Keeney KM, Wlodarska M, Finlay BB.

Clin Microbiol Rev. 2013 Oct;26(4):822-80. doi: 10.1128/CMR.00022-13. Review.

6.

Etiology of diarrhea in Bangladeshi infants in the first year of life analyzed using molecular methods.

Taniuchi M, Sobuz SU, Begum S, Platts-Mills JA, Liu J, Yang Z, Wang XQ, Petri WA Jr, Haque R, Houpt ER.

J Infect Dis. 2013 Dec 1;208(11):1794-802. doi: 10.1093/infdis/jit507. Epub 2013 Sep 16.

7.

Particle based vaccine formulations for transcutaneous immunization.

Mittal A, Raber AS, Lehr CM, Hansen S.

Hum Vaccin Immunother. 2013 Sep;9(9):1950-5. doi: 10.4161/hv.25217. Epub 2013 Jun 18. Review.

8.

Immunization with a MOMP-based vaccine protects mice against a pulmonary Chlamydia challenge and identifies a disconnection between infection and pathology.

O'Meara CP, Armitage CW, Harvie MC, Timms P, Lycke NY, Beagley KW.

PLoS One. 2013 Apr 16;8(4):e61962. doi: 10.1371/journal.pone.0061962. Print 2013.

9.

Paediatric travel medicine: vaccines and medications.

Starr M.

Br J Clin Pharmacol. 2013 Jun;75(6):1422-32. doi: 10.1111/bcp.12035. Review.

10.

High immunogenicity of nicotine vaccines obtained by intradermal delivery with safe adjuvants.

Chen X, Pravetoni M, Bhayana B, Pentel PR, Wu MX.

Vaccine. 2012 Dec 17;31(1):159-64. doi: 10.1016/j.vaccine.2012.10.069. Epub 2012 Oct 30.

11.

New routes for allergen immunotherapy.

Johansen P, von Moos S, Mohanan D, Kündig TM, Senti G.

Hum Vaccin Immunother. 2012 Oct;8(10):1525-33. doi: 10.4161/hv.21948. Epub 2012 Oct 1. Review.

12.
13.

The oral, live attenuated enterotoxigenic Escherichia coli vaccine ACE527 reduces the incidence and severity of diarrhea in a human challenge model of diarrheal disease.

Darsley MJ, Chakraborty S, DeNearing B, Sack DA, Feller A, Buchwaldt C, Bourgeois AL, Walker R, Harro CD.

Clin Vaccine Immunol. 2012 Dec;19(12):1921-31. doi: 10.1128/CVI.00364-12. Epub 2012 Oct 3.

14.

Clinical implications of enteroadherent Escherichia coli.

Arenas-Hernández MM, Martínez-Laguna Y, Torres AG.

Curr Gastroenterol Rep. 2012 Oct;14(5):386-94. doi: 10.1007/s11894-012-0277-1. Review.

15.

Adjuvants for human vaccines.

Alving CR, Peachman KK, Rao M, Reed SG.

Curr Opin Immunol. 2012 Jun;24(3):310-5. doi: 10.1016/j.coi.2012.03.008. Epub 2012 Apr 19. Review.

16.

Generation and characterization of a live attenuated enterotoxigenic Escherichia coli combination vaccine expressing six colonization factors and heat-labile toxin subunit B.

Turner AK, Stephens JC, Beavis JC, Greenwood J, Gewert C, Randall R, Freeman D, Darsley MJ.

Clin Vaccine Immunol. 2011 Dec;18(12):2128-35. doi: 10.1128/CVI.05345-11. Epub 2011 Oct 12.

17.

A combination vaccine consisting of three live attenuated enterotoxigenic Escherichia coli strains expressing a range of colonization factors and heat-labile toxin subunit B is well tolerated and immunogenic in a placebo-controlled double-blind phase I trial in healthy adults.

Harro C, Sack D, Bourgeois AL, Walker R, DeNearing B, Feller A, Chakraborty S, Buchwaldt C, Darsley MJ.

Clin Vaccine Immunol. 2011 Dec;18(12):2118-27. doi: 10.1128/CVI.05342-11. Epub 2011 Oct 12.

18.

Laser vaccine adjuvant for cutaneous immunization.

Chen X, Wu MX.

Expert Rev Vaccines. 2011 Oct;10(10):1397-403. doi: 10.1586/erv.11.112.

19.

Heat-labile- and heat-stable-toxoid fusions (LTR₁₉₂G-STaP₁₃F) of human enterotoxigenic Escherichia coli elicit neutralizing antitoxin antibodies.

Liu M, Ruan X, Zhang C, Lawson SR, Knudsen DE, Nataro JP, Robertson DC, Zhang W.

Infect Immun. 2011 Oct;79(10):4002-9. doi: 10.1128/IAI.00165-11. Epub 2011 Jul 25.

20.

New Developments in Traveler's Diarrhea.

de la Cabada Bauche J, Dupont HL.

Gastroenterol Hepatol (N Y). 2011 Feb;7(2):88-95.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk